Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles.

Annie R A McDougallRoxanne HastieMaya GoldsteinAndrew TuttleStephen TongAnne AmmerdorfferA Metin GülmezogluJoshua P Vogel

Published in: BMC medicine (2022)

This is a novel, evidence-informed approach to identifying promising candidates for pre-eclampsia prevention and treatment - a vital step in stimulating R&D of new medicines for pre-eclampsia suitable for real-world implementation.

Keyphrases

primary care
healthcare
protein kinase
quality improvement
drug induced